ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

MITRA Mithra Pharmaceuticals SA

0.216
0.00 (0.00%)
30 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Mithra Pharmaceuticals SA MITRA Euronext Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.216 01:25:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.216 0.216
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202400:00GLOBEMithra updates on offers received in the context of its..
22/4/202400:00GLOBEMithra secures court protection measures to advance..
08/3/202400:00GLOBEMithra reports full year 2023 financial results
05/3/202400:01GLOBEMithra announces changes to its executive management
05/3/202400:00GLOBEMithra initiates monetization process, receives bridge loan..
29/2/202404:42GLOBEDONESTA® safety study for menopause completes treatment..
15/2/202411:23GLOBEMithra sells shares in Mayne Pharma
06/2/202400:00GLOBEMithra updates on cash position
21/12/202310:45GLOBEMithra and Rafa Laboratories sign binding Head of Terms to..
20/12/202310:45GLOBEMithra Completes Pediatric Study of ESTELLE® in Adolescent..
18/12/202300:00GLOBEMithra Receives Positive DSMB Opinion on DONESTA® European..
04/12/202300:00GLOBEMithra and Gedeon Richter sign binding Head of Terms to..
30/11/202300:00GLOBEMithra receives guidance from the FDA for the DONESTA® NDA..
28/11/202310:45GLOBEMithra to hold five presentations on key role of estrogens..
07/11/202300:00GLOBEMithra’s NEXTSTELLIS® granted additional patent in the..
06/11/202311:52GLOBEMithra releases invitation to its extraordinary securities..
26/10/202300:00GLOBEMithra and Searchlight Pharma sign DONESTA® licensing..
23/10/202300:00GLOBEMithra to receive EUR 2.5 million milestone payment from..
17/10/202300:00GLOBEMithra’s Board of Directors to propose the removal of its..
11/10/202300:15GLOBEShareholder Letter
11/10/202300:00GLOBEMithra announces update to the agenda of its upcoming..
10/10/202311:00GLOBEMithra to Hold Presentations on Key Role of Estrogens in..
05/10/202300:00GLOBEMithra Provides an Update in the Context of Recent Market..
27/9/202300:00GLOBEMithra Announces Presentation of Positive Data on Estetrol..
26/9/202300:00GLOBEMithra Financial Results for First-Half 2023
22/9/202306:30GLOBEMithra présentera ses résultats financiers du premier..
21/9/202310:55GLOBEMithra to Hold Investor Call on H1 2023 Financial Results on..
12/9/202310:45GLOBEPublication of a Transparency Notification Received from..
11/9/202300:30GLOBELetter to Shareholders and Corporate Update
28/8/202310:45GLOBEMithra completes EUR 20 million private placement in equity..
24/8/202300:33GLOBEMithra prices private placement to raise EUR 20 million in..
08/8/202300:30GLOBEMithra and Gedeon Richter Sign Supply Agreement for..
03/8/202300:30GLOBEMithra Receives EUR 1.25 Million Milestone Payment from Fuji..
31/7/202300:30GLOBEMithra and Searchlight Pharma Announce Donesta® Licensing..
17/7/202310:45GLOBENotice of Adjustment of the Conversion Price of Mithra's..
04/7/202310:45GLOBENotice of Adjustment of the Conversion Price of Mithra's EUR..
26/6/202310:45GLOBEMithra Announces Information on the Total Number of Voting..
21/6/202313:38GLOBEMithra has access to the new EUR 12.5 million tranche of the..
15/6/202300:30GLOBEMithra Announces New Positive Preclinical Data from CSF-1R..
05/6/202310:45GLOBEMithra - Publication of a transparency notification received..
29/5/202300:30GLOBEMithra Appoints Experienced Life Sciences Executive..
25/5/202311:39GLOBEMithra’s General Meeting Of Shareholders Approves the..
25/5/202310:45GLOBEMithra’s General Meeting Of Shareholders Approves the..
25/5/202300:30GLOBEMithra - Letter to Shareholders and Corporate Update
12/5/202310:45GLOBEMithra Pharmaceuticals - Payment of the interests of the..
11/5/202300:30GLOBEMithra Announces Completion of Recruitment in Pediatric..
04/5/202300:30GLOBEMithra and the University of Liège Secure Proof-of-Concept..

Su Consulta Reciente

Delayed Upgrade Clock